TELA Bio (TELA) Other Non-Current Liabilities (2018 - 2026)

TELA Bio's Other Non-Current Liabilities history runs 9 years deep, the most recent figure standing at $1.4 million for Q1 2026.

• On a quarterly basis, Other Non-Current Liabilities rose 5.77% year-over-year to $1.4 million in Q1 2026; TTM through Mar 2026 was $1.4 million, a 5.77% increase from a year earlier, with the FY2025 full-year figure at $1.5 million, up 6.26% from the prior year.
• Other Non-Current Liabilities slipped to $1.4 million in Q1 2026 per TELA's latest filing, from $1.5 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $1.7 million in Q4 2023 and bottomed at $1.1 million in Q3 2023.
• The 5-year median for Other Non-Current Liabilities is $1.4 million (2022), against an average of $1.4 million.
• Across the five-year window, Other Non-Current Liabilities surged 16925.0% in 2022 and declined 18.78% in 2025, its largest moves.
• Year by year, Other Non-Current Liabilities stood at $1.2 million in 2022, then jumped by 36.88% to $1.7 million in 2023, then decreased by 17.51% to $1.4 million in 2024, then rose by 6.26% to $1.5 million in 2025, then decreased by 5.69% to $1.4 million in 2026.
• Per Business Quant, the three latest TELA Other Non-Current Liabilities figures stand at $1.4 million (Q1 2026), $1.5 million (Q4 2025), and $1.6 million (Q3 2025).